NCT04153188 - Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

November 13, 2020

Study Completion Date

January 5, 2021

Conditions

Erythematotelangiectatic Rosacea

Interventions

DEVICE

The Vbeam® Prima System

3 monthly Vbeam® Prima PDL treatments with a 3-day washout of topical Oxymetazoline HCL 1% cream before each treatment.

DRUG

Oxymetazoline HCL 1% Cream

Daily application of Oxymetazoline HCL 1% cream for the 6-month study.

Trial Locations (2)

Dermatology, Laser & Vein Specialists of the Carolinas, Charlotte

Dermatology & Laser Surgery Center, Houston